High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage

Medical Oncology

Volumn 31, Issue 11, 2014, Pages 1-8

  Cheng, Yu Wei ^a   Pincas, Hanna ^b   Huang, Jianmin ^c   Zachariah, Emmanuel ^d   Zeng, Zhaoshi ^e   Notterman, Daniel A ^f   Paty, Philip ^e   Barany, Francis ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; CpG methylation; LRAT; Microsatellite instability; Thermostable ligase; Universal microarray

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; LECITHIN RETINOL ACYLTRANSFERASE; MESSENGER RNA; ACYLTRANSFERASE; LECITHIN-RETINOL ACYLTRANSFERASE;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; COLORECTAL NEOPLASMS; ENZYMOLOGY; INCIDENCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TRENDS; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ACYLTRANSFERASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; YOUNG ADULT;

EID: 84919881050     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0254-7     Document Type: Article

References (32)

1. Das BC, Thapa P, Karki R, Das S, Mahapatra S, Liu TC, et al. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014;22(2):673–83.
2. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol. 2006;46:451–80.
3. Guo X, Ruiz A, Rando RR, Bok D, Gudas LJ. Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin:retinol acyltransferase in carcinoma lines. Carcinogenesis. 2000;21(11):1925–33.
4. Mahmoud LA, Robinson WA. Vitamin A levels in human bladder cancer. Int J Cancer. 1982;30(2):143–5.
5. Hayden LJ, Satre MA. Alterations in cellular retinol metabolism contribute to differential retinoid responsiveness in normal human mammary epithelial cells versus breast cancer cells. Breast Cancer Res Treat. 2002;72(2):95–105.
6. Crowe DL, Kim R, Chandraratna RA. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res. 2003;1(7):532–40.
7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.
8. Okada M, Bothin C, Blomhoff R, Kanazawa K, Midtvedt T. Vitamin A deficiency impairs colonic healing but not adhesion formation in germ-free and conventional rats. J Invest Surg. 1999;12(6):319–25.
9. Ostrowski J, Janik P, Nowacki M, Janczewska I, Przybyszewska M, Szaniawska B, et al. Serum retinol level in patients with colorectal premalignant and malignant lesions. Br J Cancer. 1987;55(2):203–5.
10. Sawicki J, Ostrowski J, Swietochowska B, Janik P, Sikora J, Słowik-Gabryelska A, et al. Vitamin A (retinol) level in colon and lung cancer patient sera. Neoplasma. 1985;32(2):225–7.
11. Jette C, Peterson PW, Sandoval IT, Manos EJ, Hadley E, Ireland CM, et al. The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L. J Biol Chem. 2004;279(33):34397–405.
12. Nadauld LD, Sandoval IT, Chidester S, Yost HJ, Jones DA. Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation. J Biol Chem. 2004;279(49):51581–9.
13. Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer. 2003;104(6):735–44.
14. Napoli JL. A gene knockout corroborates the integral function of cellular retinol-binding protein in retinoid metabolism. Nutr Rev. 2000;58(8):230–6.
15. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427–40.
16. Guo X, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, et al. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res. 2002;62(6):1654–61.
17. Boorjian S, Tickoo SK, Mongan NP, Yu H, Bok D, Rando RR, et al. Reduced lecithin:retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer. Clin Cancer Res. 2004;10(10):3429–37.
18. Guo X, Nanus DM, Ruiz A, Rando RR, Bok D, Gudas LJ. Reduced levels of retinyl esters and vitamin A in human renal cancers. Cancer Res. 2001;61(6):2774–81.
19. Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li J, et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology. 2013;145(6):1424–35.
20. Cheng YW, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, et al. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res. 2008;14(19):6005–13.
21. Cheng YW, Shawber C, Notterman D, Paty P, Barany F. Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay. Genome Res. 2006;16(2):282–9.
22. Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, et al. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer. 2010;127(3):568–77.
23. Nash GM, Gimbel M, Shia J, Culliford AT, Nathanson DR, Ndubuisi M, et al. Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer. J Clin Oncol. 2003;21(16):3105–12.
24. Ross AC, Zolfaghari R. Regulation of hepatic retinol metabolism: perspectives from studies on vitamin A status. J Nutr. 2004;134(1):269S–75S.
25. Zolfaghari R, Ross AC. Lecithin:retinol acyltransferase from mouse and rat liver. CDNA cloning and liver-specific regulation by dietary vitamin a and retinoic acid. J Lipid Res. 2000;41(12):2024–34.
26. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta. 1999;1440(2–3):139–62.
27. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7(4):536–40.
28. Worthley DL, Whitehall VL, Buttenshaw RL, Irahara N, Greco SA, Ramsnes I, et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene. 2010;29(11):1653–62.
29. Issa JP. Aging, DNA methylation and cancer. Crit Rev Oncol Hematol. 1999;32(1):31–43.
30. Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, et al. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006;66(13):6553–62.
31. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Grieu F, Watanabe G, et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer. 2006;94(4):593–8.
32. Belshaw NJ, Elliott GO, Foxall RJ, Dainty JR, Pal N, Coupe A, et al. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer. 2008;99(1):136–42.